Zhenghua Fei

606 total citations
10 papers, 401 citations indexed

About

Zhenghua Fei is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Zhenghua Fei has authored 10 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Zhenghua Fei's work include Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers) and Ginseng Biological Effects and Applications (2 papers). Zhenghua Fei is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers) and Ginseng Biological Effects and Applications (2 papers). Zhenghua Fei collaborates with scholars based in China. Zhenghua Fei's co-authors include Huafang Su, Congying Xie, Nan Wei, Zhen Zheng, Mingxia Lu, Baochai Lin, Wenfeng Li, Jun‐Feng Yin, Raoying Xie and Zuguo Yuan and has published in prestigious journals such as Toxicology and Applied Pharmacology, Biomedicine & Pharmacotherapy and Journal of Translational Medicine.

In The Last Decade

Zhenghua Fei

9 papers receiving 398 citations

Peers

Countries citing papers authored by Zhenghua Fei

Since Specialization

Citations

This map shows the geographic impact of Zhenghua Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenghua Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenghua Fei more than expected).

Fields of papers citing papers by Zhenghua Fei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenghua Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenghua Fei. The network helps show where Zhenghua Fei may publish in the future.

Co-authorship network of co-authors of Zhenghua Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenghua Fei. A scholar is included among the top collaborators of Zhenghua Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenghua Fei. Zhenghua Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Progress in Natural Drugs for Constipation Registered on Global Clinical Trials Registry Platform: A Systematic Review 2025 ·Natural Product Communications ·(unknown), Chunhua Wu, (unknown), (unknown), Zhenghua Fei, (unknown)	0
2	Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling 2019 ·Toxicology and Applied Pharmacology ·(unknown), Zhenghua Fei, Huafang Su, Raoying Xie, Liting Chen	50
3	Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer 2017 ·Journal of Pharmacological Sciences ·Honggang Wang, Zhenghua Fei, Hao Jiang	27
4	Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway 2017 ·Biomedicine & Pharmacotherapy ·Mingxia Lu, Zhenghua Fei, (unknown)	44
5	Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling 2017 ·Pharmacological Reports ·(unknown), Zhenghua Fei, Nan Wei	23
6	Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio 2017 ·Biomedicine & Pharmacotherapy ·(unknown), Zhenghua Fei, (unknown), Nan Wei	40
7	Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway 2017 ·Biomedicine & Pharmacotherapy ·Jin Jiang, Zuguo Yuan, (unknown), (unknown), Wenfeng Li, Zhenghua Fei	59
8	Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC 2015 ·Tumor Biology ·(unknown), Jun‐Feng Yin, Baochai Lin, Huafang Su, Zhen Zheng, Congying Xie, Zhenghua Fei	68
9	FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R 2015 ·Journal of Translational Medicine ·Huafang Su, Xiance Jin, Xuebang Zhang, Lihao Zhao, Baochai Lin, Lili Li, Zhenghua Fei, Lanxiao Shen, Ya Fang, Huanle Pan, Congying Xie	48
10	Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer 2015 ·Tumor Biology ·Zhenghua Fei, Xiaojuan Yu, Ming Zhou, Huafang Su, Zhen Zheng, Congying Xie	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact